Company intelligence / Profile preview

Isobionics

Geleen, Limburg, Netherlandsisobionics.com ↗

Ownership: Private
Development stage: Commercial

Overview

Isobionics produces high-purity natural flavor and fragrance ingredients using proprietary fermentation processes. Their portfolio includes citrus oil components like nootkatone and valencene as well as novel molecules such as santalol and beta-caryophyllene. The company’s products are used in the food, beverage, fragrance, and related industries.

Industry: Non-Drug Biotech

Partnerships

BASF Aroma Ingredients division (parent integration)

Beyond the preview

Go deeper on Isobionics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Isobionics.

Explore the full profile